Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction

Circulation Journal

Volumn 79, Issue 3, 2015, Pages 583-591

  Scrutinio, Domenico ^a   Agostoni, Piergiuseppe ^b,c   Gesualdo, Loreto ^d   Corra, Ugo ^a   Mezzani, Alessandro ^a   Piepoli, Massimo ^e   Di Lenarda, Andrea ^f   Iorio, Annamaria ^f   Passino, Claudio ^g,h   Magri, Damiano ⁱ   Masarone, Daniele ^j   Battaia, Elisa ^k   Girola, Davide ^l   Re, Federica ^m   Cattadori, Gaia ^b   Parati, Gianfranco ⁿ   Sinagra, Gianfranco ^f   Villani, Giovanni Quinto ^e   Limongelli, Giuseppe ^j   Pacileo, Giuseppe ^j   Guazzi, Marco ^o   Metra, Marco ^p   Frigerio, Maria ^l   Cicoira, Mariantonietta ^k   Miná, Chiara ^q   Malfatto, Gabriella ⁿ   Caravita, Sergio ⁿ   Bussotti, Maurizio ^a   Salvioni, Elisabetta ^b   Veglia, Fabrizio ^b   Correale, Michele ^r   Scardovi, Angela B ^s   Emdin, Michele ^g   Giannuzzi, Pantaleo ^a   Gargiulo, Paola ^t   Giovannardi, Marta ^b   Perrone Filardi, Pasquale ^u   Raimondo, Rosa ^a,w   Ricci, Roberto ^s   Paolillo, Stefania ^u   Farina, Stefania ^b   Belardinelli, Romualdo ^v   Passantino, Andrea ^a   La Gioia, Rocco ^a   Fiorentini, Cesare ^b   Apostolo, Anna ^b   Palermo, Pietro ^b   Contini, Mauro ^b   Bertella, Erika ^b   Mantegazza, Valentina ^b   Pietrucci, Francesca ^v   Ferraironi, Aessandro ^s   Casenghi, Matteo ⁱ   Clemenza, Francesco ^q   Roselli, Teo ^x   Buono, Andrea ^x   Calabrò, Raffaele ^x   Santoro, Daniela ^a   Campanale, Saba ^a   Caputo, Domenica ^a   Bertipaglia, Donatella ^a   Vaninetti, Raffaella ^a   Confalonieri, Marco ^f   Zambon, Elena ^f   Berton, Emanuela ^f   Torregiani, Chiara ^f   Cas, Livio Dei ^y   Carubelli, Valentina ^y   Binno, Simone ^e   Marchese, Giovanni ^a   Oliva, Fabrizio ^l   Pastormerlo, Luigi ^g   more..

^a IRCCS   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g CNR   (Italy)

^h SCUOLA SUPERIORE SANT ANNA   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j SECOND UNIVERSITY OF NAPLES   (Italy)

^k UNIVERSITY OF VERONA   (Italy)

^l OSPEDALE NIGUARDA CA GRANDA   (Italy)

^m SAN CAMILLO FORLANINI HOSPITAL   (Italy)

ⁿ UNIVERSITY OF MILANO BICOCCA   (Italy)

^o IRCCS POLICLINICO SAN DONATO   (Italy)

^p UNIVERSITY OF BRESCIA   (Italy)

^q MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^r UNIVERSITY OF FOGGIA   (Italy)

^s SPIRITO SANTO HOSPITAL   (Italy)

^t IRCCS SDN   (Italy)

^u UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^v OSPEDALI RIUNITI   (Italy)

^w Unit of Cardiac Rehabilitation   (Italy)

^x MONALDI HOSPITAL   (Italy)

^y Cardiology   (Italy)

more..

Author keywords

Heart failure; Peak exercise oxygen consumption; Prognosis; Renal function

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; SODIUM;

AGE; AIR CONDITIONING; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CLINICAL EXAMINATION; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEALTH CENTER; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MULTIPLE LINEAR REGRESSION ANALYSIS; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY QUOTIENT; RESTING HEART RATE; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; EXERCISE; FEMALE; HEART STROKE VOLUME; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADULT; AGED; CHRONIC DISEASE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; STROKE VOLUME;

EID: 84923398115     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0806     Document Type: Article

References (49)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: 1810-1852
2. de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: Contributing factors and relationship to prognosis. Eur Heart J 2006; 27: 569-581.
3. Bosselmann H, Gislason G, Gustafsson F, Hildebrandt PR, Videbaek L, Kober L, et al. Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure. Circ Heart Fail 2013; 6: 1124-1131.
4. Butler J, Chirovsky D, Phatak H, McNeill A, Cody R. Renal function, health outcomes, and resource utilization in acute heart failure: A systematic review. Circ Heart Fail 2010; 3: 726-745.
5. Acquarone N, Castello C, Antonucci G, Lione S, Bellotti P. Pharmacologic therapy in patients with chronic heart failure and chronic kidney disease: A complex issue. J Cardiovasc Med (Hagerstown) 2009; 10: 13-21.
6. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010; 122: 173-183.
7. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates- 2006. J Heart Lung Transplant 2006; 25: 1024-1042.
8. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Scientific Statement: Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012; 126: 2261-2274.
9. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20: 933-939.
10. Ewen S, Ukena C, Linz D, Schmieder RE, Bohm M, Mahfoud F. The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep 2013; 15: 370-376.
11. Adams GR, Vaziri ND. Skeletal muscle dysfunction in chronic renal failure: Effects of exercise. Am J Physiol Renal Physiol 2006; 290: F753-F761.
12. Agostoni P, Corra U, Cattadori G, Veglia F, La Gioia R, Scardovi AB, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710-2718.
13. Agostoni P, Corra U, Cattadori G, Veglia F, Battaia E, La Gioia R, et al. Prognostic value of indeterminable anaerobic threshold in heart failure. Circ Heart Fail 2013; 6: 977-987.
14. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678.
15. KDIGO (Kidney Disease: Improving Global Outcomes). 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
16. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Kitzman D, et al. Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure. Circ Heart Fail 2010; 3: 405-411.
17. Floras JS. Sympathetic nervous system activation in human heart failure: Clinical implications of an updated model. J Am Coll Cardiol 2009; 54: 375-385.
18. Parati G, Esler M. The human sympathetic nervous system: Its relevance in hypertension and heart failure. Eur Heart J 2012; 33: 1058-1066.
19. Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: Pathophysiology and therapy. Circ Res 2013; 113: 739-753.
20. White M, Yanowitz F, Gilbert EM, Larrabee P, O’Connell JB, Anderson JL, et al. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1995; 76: 1271-1276.
21. Rundqvist B, Eisenhofer G, Elam M, Friberg P. Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation 1997; 95: 940-945.
22. Notarius CF, Ando S, Rongen GA, Floras JS. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 1999; 20: 880-887.
23. Notarius CF, Millar PJ, Murai H, Morris BL, Floras JS. Inverse relationship between muscle sympathetic activity during exercise and peak oxygen uptake in subjects with and without heart failure. J Am Coll Cardiol 2014; 63: 605-606.
24. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010; 3: 537-546.
25. Bacurau AV, Jardim MA, Ferreira JC, Bechara LR, Bueno CR Jr, Alba-Loureiro TC, et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: Role of exercise training. J Appl Physiol (1985) 2009; 106: 1631-1640.
26. Brum PC, Bacurau AV, Medeiros A, Ferreira JC, Vanzelli AS, Negrao CE. Aerobic exercise training in heart failure: Impact on sympathetic hyperactivity and cardiac and skeletal muscle function. Braz J Med Biol Res 2011; 44: 827-835.
27. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96: 526-534.
28. Lang CC, Rayos GH, Chomsky DB, Wood AJ, Wilson JR. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997; 96: 238-245.
29. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corra U, Dalla Libera L, et al. Exercise intolerance in chronic heart failure: Mechanisms and therapies: Part II. Eur J Cardiovasc Prev Rehabil 2010; 17: 643-648.
30. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corra U, Dalla Libera L, et al. Exercise intolerance in chronic heart failure: Mechanisms and therapies: Part I. Eur J Cardiovasc Prev Rehabil 2010; 17: 637-642.
31. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003; 107: 1210-1225.
32. Kato J, Koike A, Hoshimoto-Iwamoto M, Nagayama O, Sakurada K, Sato A, et al. Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J 2013; 77: 661-666.
33. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Bohm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol 2011; 100: 1049-1057.
34. DiBona GF. Physiology in perspective: The wisdom of the body: Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 2005; 289: R633-R641.
35. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57: 846-851.
36. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 2009; 297: H1557-H1566.
37. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in pa- tients with chronic heart failure. Eur Heart J 2005; 26: 906-913.
38. Despas F, Detis N, Dumonteil N, Labrunee M, Bellon B, Franchitto N, et al. Excessive sympathetic activation in heart failure with chronic renal failure: Role of chemoreflex activation. J Hypertens 2009; 27: 1849-1854.
39. Oda Y, Joho S, Harada D, Hirai T, Asanoi H, Inoue H. Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity. Auton Neurosci 2010; 155: 104-108.
40. Franchitto N, Despas F, Labrunee M, Vaccaro A, Lambert E, Lambert G, et al. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol 2013; 168: 2352-2357.
41. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23: 1052-1060.
42. Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure: Skeletal muscle dysfunction and potential therapies. Circ J 2013; 77: 293-300.
43. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001; 142: 1489-1496.
44. Myers J, Arena R, Dewey F, Bensimhon D, Abella J, Hsu L, et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008; 156: 1177-1183.
45. McCullough PA, Franklin BA, Leifer E, Fonarow GC. Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure. Am J Nephrol 2010; 32: 226-233.
46. Cattadori G, Agostoni P, Corra U, Di Lenarda A, Sinagra G, Veglia F, et al. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumption. Int J Cardiol 2013; 168: 5078-5081.
47. Van Laethem C, Bartunek J, Goethals M, Verstreken S, Walravens M, De Proft M, et al. Chronic kidney disease is associated with decreased exercise capacity and impaired ventilatory efficiency in heart transplantation patients. J Heart Lung Transplant 2009; 28: 446-452.
48. Iwano H, Little WC. Heart failure: What does ejection fraction have to do with it? J Cardiol 2013; 62: 1-3.
49. Borlaug BA. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J 2014; 78: 20-32.